🔥 The Staking #etf Revolution in the US: Canary Capital Launches Injective (#İNJ )!
Another first is happening in the US crypto market! Digital asset manager Canary Capital has officially filed with the US Securities and Exchange Commission (SEC) for an Injective ($INJ )-based ETF with staking functionality. With this filing, a new player, the "Canary Staked INJ ETF," is poised to join the ranks of ETF products offering staking returns in the US.
🧩 What Does the Injective (INJ) ETF Aim For?
This new ETF offering from Canary Capital aims to track the price movements of INJ, the native token of the Injective blockchain. However, what makes this ETF unique is that it doesn't just track prices; it also offers staking rewards to investors.
ETF Features:
Name: Canary Staked INJ ETF
Tracked Asset: Injective (INJ)
Purpose: Provide both price tracking and staking returns
Benefit: The ability to earn staking income under a regulated structure without requiring technical knowledge
This product aims to offer a "safe gateway" to individual and institutional investors who want to stake but are hesitant due to technical challenges.
🌉 Why Injective Stands Out?
Injective stands out as a Layer-1 blockchain that bridges both DeFi (decentralized finance) and TradFi (traditional finance). Standing out with its high-performance architecture, low transaction fees, native staking infrastructure, and modular design, Injective made a major technical leap this year by integrating Ethereum Virtual Machine (EVM) support into its platform.
Strong Supporters:
Binance
Jump Crypto
Pantera Capital
Mark Cuban (US billionaire investor)
📈 Demand for Staking ETFs is Growing
Canary Capital's ETF move is actually part of a much larger trend. Recently, ETFs offering staking rewards have gained significant popularity, particularly among investors seeking passive income. This demand is encouraging institutional asset managers to include a staking component more prominently in their ETF applications.
What Does Canary Capital Say?
The company stated in a statement that the ETF aims to provide a more secure, regulated, and accessible solution for those seeking access to staking income without requiring technical knowledge.
⚖️ What Does the SEC Say?
The SEC generally states that staking activities can fall outside the scope of securities laws. However, to date, no ETF with staking rewards has been officially approved.
Previously launched products similar to the Solana staking ETF were launched indirectly, using different legal structures. Canary Capital's INJ ETF application could be a significant legal test for the introduction of staking-focused products in the US with a fully regulated ETF structure.
🔍 Conclusion: Is It the Threshold of a New Era in Crypto?
The staking ETF application submitted for Injective (INJ) could be a significant milestone in both the development of the crypto industry and the evolution of institutional investment. How the SEC responds to this application could determine the fate of staking-based ETFs.
If approved, Injective could make history in the crypto world not only with its technological prowess but also by positioning itself at the center of financial products.
What will happen to the price if the Injective ETF is approved?
Such a development could have a direct positive impact on the INJ price. It would both increase liquidity flow and provide more investors with access to INJ in a regulated environment.
